316 related articles for article (PubMed ID: 28053103)
1. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication
Jacobs ES; Keating SM; Abdel-Mohsen M; Gibb SL; Heitman JW; Inglis HC; Martin JN; Zhang J; Kaidarova Z; Deng X; Wu S; Anastos K; Crystal H; Villacres MC; Young M; Greenblatt RM; Landay AL; Gange SJ; Deeks SG; Golub ET; Pillai SK; Norris PJ
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053103
[TBL] [Abstract][Full Text] [Related]
2. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of host restriction factors in HIV-1 elite controllers.
Abdel-Mohsen M; Raposo RA; Deng X; Li M; Liegler T; Sinclair E; Salama MS; Ghanem Hel-D; Hoh R; Wong JK; David M; Nixon DF; Deeks SG; Pillai SK
Retrovirology; 2013 Oct; 10():106. PubMed ID: 24131498
[TBL] [Abstract][Full Text] [Related]
4. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
[TBL] [Abstract][Full Text] [Related]
5. Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
Pinzone MR; Graf E; Lynch L; McLaughlin B; Hecht FM; Connors M; Migueles SA; Hwang WT; Nunnari G; O'Doherty U
J Virol; 2016 Dec; 90(23):10436-10445. PubMed ID: 27630237
[TBL] [Abstract][Full Text] [Related]
6. Evidence for innate immune system activation in HIV type 1-infected elite controllers.
Krishnan S; Wilson EM; Sheikh V; Rupert A; Mendoza D; Yang J; Lempicki R; Migueles SA; Sereti I
J Infect Dis; 2014 Mar; 209(6):931-9. PubMed ID: 24185941
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and Chemokine Signature in Elite Versus Viremic Controllers Infected with HIV.
Platten M; Jung N; Trapp S; Flossdorf P; Meyer-Olson D; Schulze Zur Wiesch J; Stephan C; Mauss S; Weiss V; von Bergwelt-Baildon M; Rockstroh J; Fätkenheuer G; Lehmann C
AIDS Res Hum Retroviruses; 2016 Jun; 32(6):579-87. PubMed ID: 26751176
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
9. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
[TBL] [Abstract][Full Text] [Related]
11. Case report: mechanisms of HIV elite control in two African women.
Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
[TBL] [Abstract][Full Text] [Related]
12. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.
Card CM; Keynan Y; Lajoie J; Bell CP; Dawood M; Becker M; Kasper K; Fowke KR
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):427-37. PubMed ID: 22240463
[TBL] [Abstract][Full Text] [Related]
13. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
[TBL] [Abstract][Full Text] [Related]
14. Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers.
Isnard S; Royston L; Lin J; Fombuena B; Bu S; Kant S; Mabanga T; Berini C; El-Far M; Durand M; Tremblay CL; Bernard NF; Kroemer G; Routy JP
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336860
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.
Buckner CM; Kardava L; Zhang X; Gittens K; Justement JS; Kovacs C; McDermott AB; Li Y; Sajadi MM; Chun TW; Fauci AS; Moir S
J Infect Dis; 2016 Aug; 214(3):390-8. PubMed ID: 27122593
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
[TBL] [Abstract][Full Text] [Related]
17. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
18. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection.
Luo Z; Li M; Li TW; Lv Z; Ye Z; Cisneros WJ; Zhang J; Yuan L; Hultquist JF; Migueles SA; Huang L; Zhu J; Jiang W
mBio; 2022 Feb; 13(1):e0197921. PubMed ID: 35041523
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil E; Ikediobi U; Sutton RE
Yale J Biol Med; 2017 Jun; 90(2):245-259. PubMed ID: 28656011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
